540
Views
4
CrossRef citations to date
0
Altmetric
Author's View

MicroRNAs as novel immunotherapeutics

, , &
Article: e25124 | Received 17 May 2013, Accepted 21 May 2013, Published online: 28 May 2013

References

  • Kortylewski M, Kujawski M, Wang T, Wei S, Zhang S, Pilon-Thomas S, et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med 2005; 11:1314 - 21; http://dx.doi.org/10.1038/nm1325; PMID: 16288283
  • Wei J, Barr J, Kong LY, Wang Y, Wu A, Sharma AK, et al. Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway. Mol Cancer Ther 2010; 9:67 - 78; http://dx.doi.org/10.1158/1535-7163.MCT-09-0734; PMID: 20053772
  • Wu A, Wei J, Kong LY, Wang Y, Priebe W, Qiao W, et al. Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol 2010; 12:1113 - 25; http://dx.doi.org/10.1093/neuonc/noq082; PMID: 20667896
  • Wei J, Wang F, Kong LY, Xu S, Doucette T, Ferguson SD, et al. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res 2013; In press http://dx.doi.org/10.1158/0008-5472.CAN-12-4318; PMID: 23636127
  • Xu S, Wei J, Wang F, Kong L-Y, Ling X-Y, Doucette TA, et al. miR-142-3p inhibits the M2 macrophage and exerts therapeutic efficacy against murine glioblastoma. Journal of National Cancer Institute
  • Fan QW, Knight ZA, Goldenberg DD, Yu W, Mostov KE, Stokoe D, et al. A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell 2006; 9:341 - 9; http://dx.doi.org/10.1016/j.ccr.2006.03.029; PMID: 16697955
  • Mellinghoff IKWM, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ, et al. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 2005; 353:2012 - 24; http://dx.doi.org/10.1056/NEJMoa051918; PMID: 16282176
  • Hussain SF, Kong LY, Jordan J, Conrad C, Madden T, Fokt I, et al. A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients. Cancer Res 2007; 67:9630 - 6; http://dx.doi.org/10.1158/0008-5472.CAN-07-1243; PMID: 17942891
  • Ponomarev ED, Veremeyko T, Barteneva N, Krichevsky AM, Weiner HL. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway. Nat Med 2011; 17:64 - 70; http://dx.doi.org/10.1038/nm.2266; PMID: 21131957
  • Doucette TA, Rao G, Rao A, Shen L, Aldape K, Wei J, et al. Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas. Cancer Immunology Research